Skip to main content

UBS Group AG

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ALGS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$346,118
+$70,755 QoQ
Shares Held
59,986
+61.9% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 31 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. ALGS ranks #313 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALGS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $346,118 59,986
2026-03-31 $275,363 37,061
2025-12-31 $3,392 364
2025-09-30 $158,582 16,182
2025-06-30 $19,777 2,743
2025-03-31 $69,802 8,461
2024-12-31 $618,355 15,521
2024-09-30 $121 14
2024-06-30 $126 362
2024-03-31 $10,607 10,825
2023-09-30 $4,057 5,432
2023-06-30 $109 113
2023-03-31 $2,035 2,329
2021-12-31 $89,748 7,561
2021-09-30 $11,291 728
2021-06-30 $7,155 351
2021-03-31 $82,546 3,630
2020-12-31 $45,981 1,663